Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFΒ inhibition is Id1 dependent Journal Article


Authors: James, D.; Nam, H. S.; Seandel, M.; Nolan, D.; Janovitz, T.; Tomishima, M.; Studer, L.; Lee, G.; Lyden, D.; Benezra, R.; Zaninovic, N.; Rosenwaks, Z.; Rabbany, S. Y.; Rafii, S.
Article Title: Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFΒ inhibition is Id1 dependent
Abstract: Previous efforts to differentiate human embryonic stem cells (hESCs) into endothelial cells have not achieved sustained expansion and stability of vascular cells. To define vasculogenic developmental pathways and enhance differentiation, we used an endothelial cell-specific VE-cadherin promoter driving green fluorescent protein (GFP) (hVPr-GFP) to screen for factors that promote vascular commitment. In phase 1 of our method, inhibition of transforming growth factor (TGF)Β at day 7 of differentiation increases hVPr-GFP + cells by tenfold. In phase 2, TGFΒ inhibition maintains the proliferation and vascular identity of purified endothelial cells, resulting in a net 36-fold expansion of endothelial cells in homogenous monolayers, which exhibited a transcriptional profile of Id1 high VEGFR2 high VE-cadherin + ephrinB2 +. Using an Id1-YFP hESC reporter line, we showed that TGFΒ inhibition sustains Id1 expression in hESC-derived endothelial cells and that Id1 is required for increased proliferation and preservation of endothelial cell commitment. Our approach provides a serum-free method for differentiation and long-term maintenance of hESC-derived endothelial cells at a scale relevant to clinical application.
Keywords: signal transduction; controlled study; protein expression; human cell; nonhuman; flow cytometry; cell proliferation; mouse; cells, cultured; smooth muscle fiber; gene expression; cell growth; inhibitor of differentiation 1; transforming growth factor beta; embryonic stem cell; protein protein interaction; green fluorescent protein; animal experiment; cell differentiation; vasculotropin receptor 2; alpha smooth muscle actin; endothelium cell; endothelial cells; umbilical vein; transforming growth factors; stem cells; embryonic stem cells; 4 [4 (1,3 benzodioxol 5 yl) 5 (2 pyridinyl) 1h imidazol 2 yl]benzamide; inhibitor of differentiation protein 1; fluorescence activated cell sorting; clinical application; stem cell expansion; maintenance; vascular endothelial cadherin; monolayers; self assembly; ephrin b2; human embryonic stem cells; in-phase; vascular cells; vasculogenic; ve-cadherin; vegfr-2; blood vessel prostheses; fluorescent screens; yellow fluorescent protein
Journal Title: Nature Biotechnology
Volume: 28
Issue: 2
ISSN: 1087-0156
Publisher: Nature Publishing Group  
Date Published: 2010-02-01
Start Page: 161
End Page: 166
Language: English
DOI: 10.1038/nbt.1605
PUBMED: 20081865
PROVIDER: scopus
PMCID: PMC2931334
DOI/URL:
Notes: --- - "Cited By (since 1996): 10" - "Export Date: 20 April 2011" - "CODEN: NABIF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Marco Seandel
    13 Seandel
  2. Lorenz Studer
    220 Studer
  3. Robert Benezra
    146 Benezra
  4. Gabsang Lee
    21 Lee
  5. Hyung-Song Nam
    7 Nam